Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$164.99 USD
-2.37 (-1.42%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $164.96 -0.03 (-0.02%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Johnson & Johnson falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 35,153.00 | 17,941.00 | 20,878.00 | 14,714.00 | 15,119.00 |
Depreciation/Amortization & Depletion | 7,486.00 | 6,970.00 | 7,390.00 | 7,231.00 | 7,009.00 |
Net Change from Assets/Liabilities | 2,507.00 | -4,028.00 | -4,286.00 | 2,753.00 | 3,845.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -22,355.00 | 311.00 | -572.00 | -1,162.00 | -2,557.00 |
Net Cash From Operating Activities | 22,791.00 | 21,194.00 | 23,410.00 | 23,536.00 | 23,416.00 |
Property & Equipment | -4,185.00 | -3,466.00 | -2,941.00 | -3,042.00 | -233.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -17,652.00 | -60.00 | -7,323.00 | -5,810.00 |
Investments | 8,484.00 | 9,225.00 | -5,388.00 | -8,952.00 | -533.00 |
Other Investing Activities | -3,421.00 | -478.00 | -294.00 | -1,508.00 | 382.00 |
Net Cash from Investing Activities | 878.00 | -12,371.00 | -8,683.00 | -20,825.00 | -6,194.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 281.00 | -4,706.00 | -2,420.00 | -2,107.00 | -5,792.00 |
Issuance (Repayment) of Debt | -1,551.00 | -2,132.00 | -1,797.00 | 6,367.00 | -2,820.00 |
Increase (Decrease) Short-Term Debt | -1,183.00 | 9,584.00 | 807.00 | 728.00 | -61.00 |
Payment of Dividends & Other Distributions | -11,770.00 | -11,682.00 | -11,032.00 | -10,481.00 | -9,917.00 |
Other Financing Activities | -1,602.00 | 65.00 | 395.00 | -627.00 | 575.00 |
Net Cash from Financing Activities | -15,825.00 | -8,871.00 | -14,047.00 | -6,120.00 | -18,015.00 |
Effect of Exchange Rate Changes | -112.00 | -312.00 | -178.00 | 89.00 | -9.00 |
Net Change In Cash & Equivalents | 7,732.00 | -360.00 | 502.00 | -3,320.00 | -802.00 |
Cash at Beginning of Period | 14,127.00 | 14,487.00 | 13,985.00 | 17,305.00 | 18,107.00 |
Cash at End of Period | 21,859.00 | 14,127.00 | 14,487.00 | 13,985.00 | 17,305.00 |
Diluted Net EPS | 13.72 | 6.73 | 7.81 | 5.51 | 5.63 |
Fiscal Year End for Johnson & Johnson falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 7,941.00 | 3,255.00 | 35,153.00 | 31,104.00 | 5,076.00 |
Depreciation/Amortization & Depletion | 3,597.00 | 1,815.00 | 7,486.00 | 5,643.00 | 3,814.00 |
Net Change from Assets/Liabilities | -790.00 | -338.00 | 2,507.00 | -740.00 | -138.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -1,458.00 | -1,075.00 | -22,355.00 | -21,079.00 | -1,313.00 |
Net Cash From Operating Activities | 9,290.00 | 3,657.00 | 22,791.00 | 14,928.00 | 7,439.00 |
Property & Equipment | -1,210.00 | -597.00 | -4,185.00 | -2,717.00 | -1,871.00 |
Acquisition/ Disposition of Subsidiaries | -14,807.00 | -1,811.00 | 0.00 | 0.00 | 0.00 |
Investments | 522.00 | 349.00 | 8,484.00 | 5,806.00 | 2,189.00 |
Other Investing Activities | 1,344.00 | 1,595.00 | -3,421.00 | -1,009.00 | -779.00 |
Net Cash from Investing Activities | -14,151.00 | -464.00 | 878.00 | 2,080.00 | -461.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -1,321.00 | -1,280.00 | 281.00 | 310.00 | 577.00 |
Issuance (Repayment) of Debt | 5,856.00 | 1.00 | -1,551.00 | -502.00 | 7,173.00 |
Increase (Decrease) Short-Term Debt | 10,061.00 | 4,373.00 | -1,183.00 | -1,136.00 | -1,390.00 |
Payment of Dividends & Other Distributions | -5,854.00 | -2,869.00 | -11,770.00 | -8,905.00 | -6,034.00 |
Other Financing Activities | -652.00 | 321.00 | -1,602.00 | -937.00 | -179.00 |
Net Cash from Financing Activities | 8,090.00 | 546.00 | -15,825.00 | -11,170.00 | 147.00 |
Effect of Exchange Rate Changes | -210.00 | -125.00 | -112.00 | -237.00 | -69.00 |
Net Change In Cash & Equivalents | 3,019.00 | 3,614.00 | 7,732.00 | 5,601.00 | 7,056.00 |
Cash at Beginning of Period | 21,859.00 | 21,859.00 | 14,127.00 | 14,127.00 | 14,127.00 |
Cash at End of Period | 24,878.00 | 25,473.00 | 21,859.00 | 19,728.00 | 21,183.00 |
Diluted Net EPS | 1.93 | 1.34 | 1.58 | 10.21 | 1.96 |